One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A wake-up call for sleep in rheumatic diseases
doi : 10.1016/S2665-9913(22)00311-3
Volume 4, Issue 11, November 2022, Page e739
Suspending methotrexate for 2 weeks after COVID-19 vaccination
doi : 10.1016/S2665-9913(22)00265-X
Volume 4, Issue 11, November 2022, Pages e740-e741
Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease
doi : 10.1016/S2665-9913(22)00256-9
Volume 4, Issue 11, November 2022, Pages e741-e743
Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes
doi : 10.1016/S2665-9913(22)00229-6
Volume 4, Issue 11, November 2022, Pages e743-e745
Predicting outcomes in systemic sclerosis by skin involvement and autoantibodies
Janet E Pope a
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
doi : 10.1016/S2665-9913(22)00221-1
Volume 4, Issue 11, November 2022, Pages e747-e750
Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
doi : 10.1016/S2665-9913(22)00251-X
Volume 4, Issue 11, November 2022, Pages e751-e752
Jean Liew: from Bronte scholar to social media influencer
Jennifer Thorley
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
doi : 10.1016/S2665-9913(22)00228-4
Volume 4, Issue 11, November 2022, Pages e755-e764
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
doi : 10.1016/S2665-9913(22)00227-2
Volume 4, Issue 11, November 2022, Pages e765-e774
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study
doi : 10.1016/S2665-9913(22)00216-8
Volume 4, Issue 11, November 2022, Pages e775-e784
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort
Muriel Elhai PhD a b *, Nanthara Sritharan MSc c *, Marouane Boubaya MSc c, Alexandra Balbir-Gurman MD d, Elise Siegert MD e, Eric Hachulla PhD f, Jeska de Vries-Bouwstra PhD g, Gabriela Riemekasten MD h, Jörg H W Distler MD i, Edoardo Rosato MD j, Francesco Del Galdo PhD k, Fabian A Mendoza MD l, Daniel E Furst MD m, Carlos de la Puente PhD n, Anna-Maria Hoffmann-Vold PhD o, Armando Gabrielli MD p q, Oliver Distler MD b, Coralie Bloch-Queyrat PhD c, Yannick Allanore PhD MD a
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
Michael Hughes PhD a b, Prof Yannick Allanore PhD c, Murray Baron MD d, Prof Francesco Del Galdo PhD e f, Prof Christopher P Denton PhD g, Tracy Frech MD h, Prof Daniel E Furst MD i j k, Ilaria Galetti l, Prof Lorenzo Dagna MD m, Prof Ariane L Herrick MD b n, Prof Masataka Kuwana PhD o, Prof Pietro Matucci-Cerinic PhD i j m p, Zsuzsanna H McMahan MD q, Charles D Murray PhD d, Prof Susanna Proudman MBBS r s, Prof Marco Matucci-Cerinic PhD i j m p
Monkeypox associated acute arthritis
doi : 10.1016/S2665-9913(22)00257-0
Volume 4, Issue 11, November 2022, Page e804
